These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21747029)

  • 41. Prescribing Trends of Atypical Antipsychotic Drugs in an Outpatient Unit of a Child and Adolescent Clinic in Turkey.
    Yektaş Ç; Tufan AE
    Clin Neuropharmacol; 2018; 41(1):23-27. PubMed ID: 29303800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychosis in Parkinson's disease: therapeutic options.
    Hasnain M
    Drugs Today (Barc); 2011 May; 47(5):353-67. PubMed ID: 22013566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors related to antipsychotic oversupply among Central Texas Veterans.
    Yang M; Barner JC; Worchel J
    Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants Of Antipsychotic Drugs Prescription Among Community-Living Older Adults With Dementia: A Population-Based Study Using Health Information Systems In The Lazio Region, Italy.
    Bargagli AM; Cascini S; Agabiti N; Kirchmayer U; Marino C; Davoli M
    Clin Interv Aging; 2019; 14():2071-2083. PubMed ID: 31819389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychosis in Parkinson Disease: A Review of Etiology, Phenomenology, and Management.
    Samudra N; Patel N; Womack KB; Khemani P; Chitnis S
    Drugs Aging; 2016 Dec; 33(12):855-863. PubMed ID: 27830568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antipsychotic prescribing for Alzheimer's disease and related disorders in specialized settings from 2010 to 2014 in France: a repeated cross-sectional study.
    Tifratene K; Manera V; Fabre R; Gros A; Thummler S; Pradier C; Robert P; David R
    Alzheimers Res Ther; 2017 Apr; 9(1):34. PubMed ID: 28446209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study.
    Murphy AL; Gardner DM; Cooke C; Kisely S; Hughes J; Kutcher SP
    BMC Psychiatry; 2013 Jul; 13():198. PubMed ID: 23890157
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prescription practices of antipsychotic medication in early psychosis: a two-year follow-up survey of subjects admitted in two psychiatric hospitals of South-Western France].
    Grolleau A; Cougnard A; Parrot M; Kalmi E; Desage A; Misdrahi D; Brun-Rousseau H; Verdoux H
    Encephale; 2007; 33(3 Pt 1):326-31. PubMed ID: 17675930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of antipsychotic use with hospital events and mortality among medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Ryder PT; Qian J; Zuckerman IH; Shaffer T; Zhao L
    Am J Geriatr Psychiatry; 2009 May; 17(5):417-27. PubMed ID: 19390299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study.
    Sultana J; Fontana A; Giorgianni F; Pasqua A; Cricelli C; Spina E; Gambassi G; Ivanovic J; Ferrajolo C; Molokhia M; Ballard C; Sharp S; Sturkenboom M; Trifirò G
    CNS Drugs; 2016 Nov; 30(11):1097-1109. PubMed ID: 27423216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.
    Jano E; Johnson M; Chen H; Aparasu RR
    Curr Med Res Opin; 2008 Mar; 24(3):709-16. PubMed ID: 18226325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
    Weintraub D; Hurtig HI
    Am J Psychiatry; 2007 Oct; 164(10):1491-8. PubMed ID: 17898337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring for metabolic side effects among outpatients with dementia receiving antipsychotics.
    Mittal D; Li C; Viverito K; Williams JS; Landes RD; Thapa PB; Owen R
    Psychiatr Serv; 2014 Sep; 65(9):1147-53. PubMed ID: 24829056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

  • 58. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
    Maher AR; Theodore G
    J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
    Barnett MJ; Wehring H; Perry PJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.